Drug hypersensitivity: Insights into pathomechanisms

European Annals of Allergy and Clinical Immunology

Volumn 37, Issue 6, 2005, Pages 207-212

  Martin, E ^a   Mayorga, C ^a   Rodriguez, R ^a   Torres, M J ^a   Blanca, M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; HAPTEN; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; ISOMETHEPTENE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PENICILLOIC ACID; PEPTIDOLEUKOTRIENE; SULFAMETHOXAZOLE; TRYPTASE;

ANAPHYLAXIS; ARTICLE; CELL CLONE; COOMBS TEST; DISEASE COURSE; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; EFFECTOR CELL; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; SKIN ALLERGY; T LYMPHOCYTE;

CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HAPTENS; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; KERATINOCYTES; KILLER CELLS, NATURAL; LEUKOCYTES; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 22444437792     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Demoly P., Bousquet J. - Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001;1(4):305-10.
2. Levine B.-B. - Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med. 1966;275:1115-25.
3. Roujeau J.-C., Stern R.-S. - Severe cutaneous adverse reactions to drugs. N Engl J Med 1994;331:1272-1285.
4. Torres M.-J., Blanca M., de Weck A., Fernandez J., Demoly P., Romano A., Abereer W., ENDA and the EAACI interest group on drug hypersensitivity. - Diagnosis of immediate allergic reactions to betalactam antibiotics. Allergy 2003;58:854-63.
5. Romano A., Blanca M., Torres M.-J., Bircher A., Aberer W., Brockow K., Pichler W.-J., Demoly P., ENDA and the EAACI interest group on drug hypersensitivity. - Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy 2004;59:1153-1160.
6. Levine B.-B. - Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med 1966;275:1115-1125.
7. Descotes J., Choquet-Kastylevsky G. - Gell and Coombs's classification: is it still valid?. Toxicology 2001;158:43-49.
8. Pichler W.-J. - Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-693.
9. th edn. Mosby, 1998:1104-1122.
10. Batchelor F.-R., Dewdney J.-M., Gazzard D. - Penicillin allergy. The formation of the penicilloyl determinant. Nature 1965;206:362-364.
11. Levine B.-B. et al. - Studies on the formation of the penicillin antigen. Arch Biophys. 1961;93:50-5.
12. Levine B.-B., Ovary Z. - Studies of the mechanism of the formation of the penicillin antigen III. The N(D-(Benzyl penicilloyl)) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J Exp Med, 1961;114:875.
13. Atsumi T., Nishida K., Kinoshida Y., Shibata K., Horiuchi Y. - The heterogeneity of combining sites of anti-benzylpeniciloyl antibodies obtained from a individual rabbits: Fractionation of antibodies with a specific immunoadsorbent. J Immunol 1967;99:1286-1293.
14. Blanca M., García J., Vega J.-M., Miranda A., Carmona M.-J., Mayorga C., Moreno F., Juárez C. - Anaphylaxis to penicillins after non-therapeutic exposure: an immunological investigation. Clin Exp Allergy 1996;26:335-340.
15. Fukushima H., Misaki R., Takechi M., Niinomi Y., Harada M. - Mouse anti-benzyl-penicilloyl IgE monoclonal antibody: preparation, characterization and cross-reactivity. Clin Exp Immunol 1987;68:427-436.
16. De Haan P., Jonge A.-J., Verbrugge E., Boorsma D.-M. - Three epitope-specific monoclonal antibodies against the hapten peni-ci-llin. Int Arch Allergy Appl Immunol 1985;76:42-46.
17. Mayorga C., Obispo T., Jimeno L., Blanca M., Moscoso del Prado J., Carreira J., Garcia J.-J., Juarez C. - Epitope mapping of betalactam antibiotics with the use of monoclonal antibodies. Toxicology 1995;97:225-234. TENEMOS
18. Romano A., Quarantino D., Aimone-Gastin I., Mayorga C., Papa G., Venuti A. et al. - Cefalosporin allergy: Characterization of unique and cross-reacting cephalosporin antigens. Int. I. Inmunopathol Pharmacol 1997;10:187-191.
19. Kanny G., Guenard L., Demoly P., Ponvert C., Grand J., Gallen C. et al. - Severe Drug Allergy: The First 100 Cases Declared to Allergy Vigilance Network. J Allergy Clin Immunol 2008;115:5183.
20. Miranda A., Blanca M., Vega J.-M., Moreno F., Carmona M.-J., Garcia J.-J. et al. - Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996;98:671-677.
21. Romano A., Mayorga C., Torres M.-J., Artesani M.-C., Suau R., Pérez E. et al. - Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol 2000;106:1177-1183.
22. Levine B.-B., Redmond A.-P. - Minor haptenic determinant specific reagins of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 1969a;35:445-455.
23. Stevenson D.-D., Simon R.-A., Zaraw B.-L. - Selective response AINES. Sensitivity to aspirin and non steroiclal antiinflammatory drugs. 1695-1710. In Adkinson NF, Yuginger JW, Busse WW, Bochner BS, Holgate ST and Simmons FE. Allergy. Principles and Practice. Mosby 2003, Philadelphia.
24. Nyfeler B., Pichler W.-J. - The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997;27:175-81.
25. Luque I., Leyva L., Torres M.-J., Rosal M., Mayorga C., Segura J.-M., Blanca M., Juarez C. - In vitro T lymphocyte responses to betalactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56:611-618.
26. Hari Y., Frutig-Schnyder K., Hurni M., Yawalkar N., Zanni M.-P., Schnyder B., Kappeler A., von Greyerz S., Braathen L.-R., Pichler W.-J. - T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001;31:1398-408.
27. Correia O., Delgado L., Ramos J.-P., Resende C., Fleming Torrinha J.-A. - Cutaneous T-cell recruitmen in toxic epidermal necrolysis, further evidence of CD8+ lymphocyte involvement. Arch Dermatol 1993;129:466-468.
28. Romano A., Di Fonso M., Papa G., Pietroantonio F., Federico F., Fabrizi G., Venuti A. - Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995;50:113-118.
29. Terrados S., Blanca M., Garcia J., Vega J.-M., Torres M.-J., Carmona M.-J., Miranda A., Moya M.-C., Juarez C., Fernandez J. - Non-immediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995;50:563-567.
30. Ozawa H., Aiba S., Nakagawa, Tagami H. - Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol 1996;26:648-52.
31. Aiba S., Katz S.-I. - Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 1990;145:2791-6.
32. Schwarzenberger K., Udey M.-C. - Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996;106:553-8.
33. Arrighi J.-F., Rebsamen M., Rousset F., Kindler V., Hauser C. - A critical role for p38 mitogen-activated protein kinase in the maturation ofhuman blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol. 2001;166:3837-45.
34. Dudda J.-C., Simon J.-C., Stefan M. - Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J Immunol 2004;172:857-863.
35. Kalinski P., Hilkens C.-M., Wierenga E.-A., Kapsenberg M.-L. - Kapsenberg T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999;20:561-7.
36. Banchereau J., Steinmann R.-M. - Dendritic cells and the control of the immunity. Nature 1998;382:245.
37. Banchereau J., Briere f., Caux C. et al. - Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
38. Lutz M.-B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002 Sep;23(9):445-9.
39. Macatonia S.-E., Hosken N.-A., Litton M. et al. - Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-9.
40. Matzinger P. - The danger model: a renewed sense of self. Science 2002;296:301-5.
41. Heath W.-R., Carbone F.-R. - Immunology: dangerous liaisons. Nature 2003;425:460-1.
42. Gallucci S., Lolkema M., Matzinger P. - Natural adjuvants: endogenous activators of dendritic cells. Nature Medicine 1999;5:1249-55.
43. Shi Y., Evans J.-E., Rock K.-L. - Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-21.
44. Kaisho T., Akira S. - Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 2000;20:393-405.
45. Gorden K.-B., Gorski K.-S., Gibson S.-J., Kedl R.-M., Kieper W.-C., Qiu X., Tomai M.-A., Alkan S.-S., Vasilakos J.-P. - Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005;174:1259-68.
46. Leyva L., Torres M.-J., Posadas S., Blanca M., Besso G., O'Valle F., del Moral R.-G., Santamaria L.-F., Juarez C. - Anticonvulsant induced toxic epidermal necrolysis: Monitoring the immunological response. J Allergy Clin Immunol 2000;105:157-65.
47. Tapia B., Padial A., Sanchez-Sabate E., Alvarez-Ferreira J., Morel E., Blanca M., Bellon T. - Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 2004;114:335-40.
48. Posadas S.-J., Leyva L., Torres M.-J., Rodriguez J.-L., Bravo I., Rosal M., Fernandez J., Juarez C., Blanca M. - Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000;106:769-776.
49. Posadas S.-J., Padial A., Torres M.-J., Mayorga C., Leyva L., Sanchez E., Alvarez J., Romano A., Juarez C., Blanca M. - Delayed reactions to drugs show a Th1 profile and levels of perform, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002;109:155-161.